Advertisement

Implantable Atrial Defibrillator: What are the Results of Initial Experience?

  • G. Gasparini
  • A. Bonso
  • S. Themistoclakis
  • F. Giada
  • A. Corrado
  • A. Raviele
Conference paper

Abstract

Atrial fibrillation (AF) is the most common arrhythmia in clinical practice for which patients are hospitalized, engendering high human and economic costs [1, 2]. The limited efficacy and the side effects of drugs used both to maintain sinus rhythm and to control the heart rate have increased interest in the development of non-pharmacological therapy for AF [3]. The implantable atrial defibrillator (IAD) is one such therapeutic tool.

Keywords

Atrial Fibrillation Sinus Rhythm Atrial Tachycardia Atrial Fibrillation Recurrence Maintain Sinus Rhythm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bialy D, Lehmann MH, Schumacher DN, Steinman RT, Meissner MD (1992) Hospitalization for arrhythmias in the United States: importance of atrial fibrillation. J Am Coll Cardiol 19:41A (abstr)Google Scholar
  2. 2.
    Wolf PA, Mitchell JB, Baker CS, Kannel WB, D’Agostino RB (1995) Mortality and hospital costs associated with atrial fibrillation. Circulation 92:I–140 (abstr)Google Scholar
  3. 3.
    Keane D, Zou L, Ruskin J (1998) Nonpharmacologic therapies for atrial fibrillation. Am J Cardiol 81:C41–C45CrossRefGoogle Scholar
  4. 4.
    Levy S, Ricard P, Lau CP et al (1997) Multicenter low energy transvenous atrial defibrillation. J Am Coll Cardiol 29:750–755PubMedCrossRefGoogle Scholar
  5. 5.
    Wijffels MCEF, Kirchof CJHJ, Dorland R, Allessie MA (1995) Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 92:1954–1968PubMedCrossRefGoogle Scholar
  6. 6.
    Wellens HJJ, Lau CP, Lüderitz B et al (1998) Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation 98:1651–1656PubMedCrossRefGoogle Scholar
  7. 7.
    Timmermans C, Wellens HJJ (1998) Effect of device-mediated therapy on symptomatic episodes of atrial fibrillation. J Am Coll Cardiol 31:331A (abstr)CrossRefGoogle Scholar
  8. 8.
    Wharton M (1998) Treatment of spontaneous atrial tachyarrhythmias with the Medtronic 7250 Jewel AF: worldwide clinical experience. Circulation 98:I–190 (abstr)Google Scholar
  9. 9.
    Sulke N, Bailin SJ, Swerdlow CD, for the Worldwide 7250 Jewel AF-Only Investigators (1999) Worldwide clinical experience with a dual chamber implantable cardioverter defibrillator in patients with atrial fibrillation and flutter. Eur Heart J (in press) (abstr)Google Scholar
  10. 10.
    Raviele A, Gasparini G, Bonso A et al (1998) Trattamento non farmacologico della fibrillazione atriale parossistica refrattaria ai farmaci: defibrillatore atriale o ablazione + pacemaker? In: Alboni P (ed) Controversies in clinical arrhythmology. Cento (FE), pp 118–120Google Scholar
  11. 11.
    Raviele A, Brignole M, Menozzi C et al (1998) Development of an implantable drug delivery system for the treatment of vasovagal syncope: a dream or a real prospect? In: Raviele A (ed) Cardiac arrhythmias 1997. Springer, Milano, pp 422–427Google Scholar

Copyright information

© Springer-Verlag Italia 2000

Authors and Affiliations

  • G. Gasparini
    • 1
  • A. Bonso
    • 1
  • S. Themistoclakis
    • 1
  • F. Giada
    • 1
  • A. Corrado
    • 1
  • A. Raviele
    • 1
  1. 1.Reparto di CardiologiaOspedale Umberto IMestre, VeniceItaly

Personalised recommendations